Intranasal ketamine (esketamine) or Spravato offers a new path for people who have not found relief with traditional treatments for depression and other mood disorders. Carefully monitored nasal-spray protocols are becoming more accessible as a treatment option. They act quickly, integrate smoothly into structured mental-health programs, and support recovery in a compassionate, clinically rigorous setting.
January 29, 2026
